Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.

IF 15.1 1区 医学 Q1 PSYCHIATRY
Broc A Pagni, Richard J Zeifman, Sarah E Mennenga, Brennan M Carrithers, Noam Goldway, Snehal Bhatt, Kelley C O'Donnell, Stephen Ross, Michael P Bogenschutz
{"title":"Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.","authors":"Broc A Pagni, Richard J Zeifman, Sarah E Mennenga, Brennan M Carrithers, Noam Goldway, Snehal Bhatt, Kelley C O'Donnell, Stephen Ross, Michael P Bogenschutz","doi":"10.1176/appi.ajp.20230887","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Evidence suggests that psilocybin-assisted therapy (PAT) leads to durable shifts in personality structure. However, such changes have yet to be characterized in disorders of addiction. In this secondary analysis from a randomized controlled trial, the authors examined the effect of PAT on personality dimensions in patients with alcohol use disorder (AUD), hypothesizing that PAT would attenuate personality abnormalities in AUD and that reductions in trait impulsiveness would be associated with lower drinking.</p><p><strong>Methods: </strong>Eighty-four adults with AUD were randomized to two medication sessions of either psilocybin (N=44) or active placebo (diphenhydramine; N=40), received 12 weekly psychotherapy sessions, and completed follow-up for an additional 24 weeks. Changes in personality traits (week 36 vs. baseline) were assessed with the revised NEO Personality Inventory; daily alcohol consumption was quantified using the timeline followback.</p><p><strong>Results: </strong>Relative to the placebo group, the psilocybin group showed significant reductions in neuroticism and increases in extraversion and openness. Secondary analyses showed that reductions in neuroticism were driven by decreases in the facets depression, impulsiveness, and vulnerability; increases in openness were driven by increases in the facets openness toward feelings and fantasy. Across all participants, decreases in impulsiveness were associated with lower posttreatment alcohol consumption, and an exploratory analysis revealed that these associations were strongest among psilocybin-treated participants who continued moderate- or high-risk drinking prior to the first medication session.</p><p><strong>Conclusions: </strong>PAT elicited durable shifts in personality, suggesting normalization of abnormal personality trait expression in AUD. Further study is needed to clarify whether PAT exerts its beneficial effects by reducing impulsiveness or whether impulsive individuals inherently respond better to PAT.</p>","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":"182 1","pages":"114-125"},"PeriodicalIF":15.1000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1176/appi.ajp.20230887","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Evidence suggests that psilocybin-assisted therapy (PAT) leads to durable shifts in personality structure. However, such changes have yet to be characterized in disorders of addiction. In this secondary analysis from a randomized controlled trial, the authors examined the effect of PAT on personality dimensions in patients with alcohol use disorder (AUD), hypothesizing that PAT would attenuate personality abnormalities in AUD and that reductions in trait impulsiveness would be associated with lower drinking.

Methods: Eighty-four adults with AUD were randomized to two medication sessions of either psilocybin (N=44) or active placebo (diphenhydramine; N=40), received 12 weekly psychotherapy sessions, and completed follow-up for an additional 24 weeks. Changes in personality traits (week 36 vs. baseline) were assessed with the revised NEO Personality Inventory; daily alcohol consumption was quantified using the timeline followback.

Results: Relative to the placebo group, the psilocybin group showed significant reductions in neuroticism and increases in extraversion and openness. Secondary analyses showed that reductions in neuroticism were driven by decreases in the facets depression, impulsiveness, and vulnerability; increases in openness were driven by increases in the facets openness toward feelings and fantasy. Across all participants, decreases in impulsiveness were associated with lower posttreatment alcohol consumption, and an exploratory analysis revealed that these associations were strongest among psilocybin-treated participants who continued moderate- or high-risk drinking prior to the first medication session.

Conclusions: PAT elicited durable shifts in personality, suggesting normalization of abnormal personality trait expression in AUD. Further study is needed to clarify whether PAT exerts its beneficial effects by reducing impulsiveness or whether impulsive individuals inherently respond better to PAT.

酒精使用障碍患者在裸盖菇素辅助治疗后的多维人格改变:一项双盲、安慰剂对照临床试验的结果
目的:有证据表明裸盖菇素辅助治疗(PAT)可导致人格结构的持久改变。然而,这种变化尚未在成瘾障碍中表现出来。在一项随机对照试验的二次分析中,作者检验了PAT对酒精使用障碍(AUD)患者人格维度的影响,并假设PAT会减轻AUD患者的人格异常,而特质冲动的减少与饮酒减少有关。方法:84名成年AUD患者随机分为两组,一组服用裸盖菇素(N=44),另一组服用活性安慰剂(苯海拉明;N=40),每周接受12次心理治疗,并完成另外24周的随访。使用修订后的NEO人格量表评估人格特征的变化(第36周与基线相比);每日饮酒量通过时间轴随访进行量化。结果:与安慰剂组相比,裸盖菇素组的神经质程度明显降低,外向性和开放性明显增加。二次分析表明,神经质的减少是由抑郁、冲动和脆弱等方面的减少所驱动的;开放性的增加是由对感情和幻想的开放性的增加所驱动的。在所有的参与者中,冲动的减少与治疗后较低的饮酒量有关,一项探索性分析显示,这些关联在接受裸盖菇素治疗的参与者中最为强烈,他们在第一次服药前继续中度或高风险饮酒。结论:PAT诱发了持久的人格转变,提示AUD患者异常人格特质表达正常化。PAT是否通过减少冲动来发挥其有益作用,还是冲动个体天生对PAT有更好的反应,还需要进一步的研究来阐明。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Psychiatry
American Journal of Psychiatry 医学-精神病学
CiteScore
22.30
自引率
2.80%
发文量
157
审稿时长
4-8 weeks
期刊介绍: The American Journal of Psychiatry, dedicated to keeping psychiatry vibrant and relevant, publishes the latest advances in the diagnosis and treatment of mental illness. The journal covers the full spectrum of issues related to mental health diagnoses and treatment, presenting original articles on new developments in diagnosis, treatment, neuroscience, and patient populations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信